Albert David Limited

ALBERTDAVD
NSE· Healthcare
₹686.65
+2.40 (+0.35%)
52W Low · ₹602.1552W High · ₹918.80
Near 52W Low
Market Cap
₹398.56L Cr
Volume
692
Prev Close
₹698.35
ISIN
INE155C01010

Orion Score

Fundamentals-based quality & risk · not a recommendation

47/100
Caution

Albert David Limited scores 47/100 (Caution) on the Orion Score — weak business quality (44), poor growth (25), moderate balance-sheet safety (50) and cheap valuation (82). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
44
Growth
25
Safety
50
Value
82

Full Orion analysis

Risk checks

  • Weak cash conversion (CFO 0.4x PAT) with modest returns
  • Very weak fundamentals (Piotroski F 1/9)

Forensic accounting

Piotroski F 1/9Altman Z Safe(6.89)Beneish M Clean(-2.23)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

38/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Low Debt
D/E 0.08x — lean balance sheet
QUALITY
Low Quality
ROCE -1.1% — poor capital efficiency
MOMENTUM
Bearish
RSI 41.7 — weak momentum

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
42.73
ROCE
-1.06%
ROE (1Y)
-0.38%
D/E Ratio
0.08x
OPM
0.04%
TTM EPS
₹-2.60
Dividend Yield
73.00%
Qtrly Sales
₹85.86 Cr
Qtrly Profit
₹-21.43 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹85.86₹-21.430.0%₹-37.56
Q3 2026₹89.93₹15.39.3%₹26.81
Q2 2026₹87.24₹-3.30.4%₹-5.79
Q1 2026₹70.57₹7.94-18.5%₹13.91
Q4 2025₹74.89₹-10.33-8.8%₹-18.10

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2025₹343.25₹17.2₹32.49-0.8%
FY 2024₹360.26₹75.42₹104.3211.4%
FY 2023₹340.01₹36.17₹59.6210.8%
FY 2022₹312.43₹35.26₹56.510.3%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
ALBERTDAVD ★₹399 Cr42.73-1.06%-0.38%0.08x0.04%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹88,148 Cr25.3912.55%9.93%0.21x15.11%
ASTERDM₹68,390 Cr104.348.93%10.07%0.46x13.98%
ABBOTINDIA₹59,509 Cr38.2836.31%34.46%0.04x27.01%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹511.42₹497.99₹423.39₹401.23
Equity₹392.48₹382.98₹311.57₹279.47
Total Debt₹12.32₹3.32₹5.32₹5.66
Cash₹0.42₹5.44₹1.45₹2.28
Net Debt₹9.63—₹2.52₹1.49
Working Capital₹249.87₹272.59₹205.3₹146.03

Shareholding Pattern

Q1 FY2027

Promoter
64.04%
FII
0.89%
DII
0.72%
Public
34.35%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202764.04%0.89%0.72%34.35%
Q4 FY202664.05% ↑0.89% ↑0.72% ↓34.34% ↓
Q3 FY202662.23%0.6%1.65%35.51%
Q2 FY202662.23%0.6% ↓1.65%35.5% ↑
Q1 FY202662.23%0.84% ↓1.65% ↑35.27% ↑
Q4 FY202562.23% ↑1% ↑1.64% ↑35.12% ↓
Q3 FY202562.13%0.86% ↓1.63%35.39% ↑
Q2 FY202562.13%0.88%1.63%35.36%

Corporate Actions

Ex-DateActionDetails
2026-07-30
DIVIDEND
Dividend - Rs 5 Per Share

Analyse ALBERTDAVD with Orion AI

Ask: "Is Albert David Limited stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Albert David Limited (ALBERTDAVD) Stock

Albert David Limited is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE155C01010. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.